Atlas Trials

A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors

Clinical trial NCT01517464 · COMPLETED

Trial details

NCT number
NCT01517464
Sponsor
SynerGene Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasm
Start date
2012-01-01
Primary completion
2015-12-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.